I began this London-based Biotech start-up with the vision of a world in which medication and treatments would be affordable, easily accessible, gene-specific and tailored to the specified needs of patients.
Happy!! to announce the approval of An & An Global Malaria and HIV test kits by Ghana FDA in West Africa on 7th February, 2022 (certificates available upon request).
An & An Global is currently ACTIVE IN OVER 25 COUNTRIES GLOBALLY and believes in collective global efforts for solving global healthcare problems. We believe that our diversity makes us stronger hence, we are keen to hear from institutions, scientists, and collaborators with interests aligned to ours for mutually-beneficial cooperation.
An & An Global is an expert you can count on in establishing and sourcing equipment for hospitals, pharmaceutical and biochemical manufacturing plants worldwide.
We have a pool of experts in over 25 countries ready to assist with your query and are very hands-on in helping industries reach and exceed their full potential.
An & An Global is involved in the global distribution of HIV, Malaria, COVID-19 lateral flow, Med-Fit TENS & Vagus Nerve stimulator pain management devices (exclusive distributor for Africa) and many more.
We are helping in the fight against COVID-19 by aiding in the development and distribution of COVID-19 lateral flow test kits in Europe, Africa and Asia. We ensure that our clients are provided with highly sensitive, specific and state of the art lateral flow test kits. We have our in-house An & An Global test kits and also authorised distributors for Sona Nanotech.
We have excellent expertise on the requirements of regulatory bodies (especially in Europe and Africa) for the registration and regulation of medical devices and medications by offering consultancy services in this regard to companies seeking to get their products approved by global (especially African) regulatory bodies .
As part of our efforts to facilitate knowledge transfer and advanced research, we provide research consultation for researchers across the globe in a broad array of subjects. If you're a researcher with pressing issues requiring a solution, don't hesitate to contact us using the contact form at the bottom of this page or by pressing the (yellow and black) chat box and we will be in touch immediately.
An & An Biotech is responding to COVID-19 by working with our partners on a system which indicates the number of shoppers in-store at any given point in time and help customers to avoid overcrowding. As a bonus, this system will also tell customers the location of in-store items and their stock levels to avoid unnecessary movements around the shops and also save time spent shopping.
This new venture is proceeding rapidly hence we are keen to hear from companies and collaborators who would like form part of our trial zones.
One of the key focal areas of An & An Global is developing pharmacogenomic modules which will enable Doctors to prescribe medication to patients based on their genetic outlook, hence minimising side-effects as much as possible.
Our current focus is on beta-blocker anti-hypertensives and anti-cholesterol statins. A research conducted in the UK on 165,000 patients and reported on the BBC highlighted limited effectiveness of statins in 50% of subjects treated. With gene-specific prescriptions of statins, this percentage could be increased significantly.
We have a strong belief that high quality medication should be affordable especially for low income families in developing countries. This can be made possible via cutting-edge technology and know-how. An & An Global is passionate about using our technical and financial resources to help in the production and supply of affordable medicines and natural wellness products globally.
Our current focus is on Africa, Asia and Middle East. You can read more about one of such projects which we are facilitating in the projects section. We welcome collaborators who share this dream and passion with interest in beginning a similar venture in other parts o the world with us.
An & An Global has a primary aim to develop tomorrow's biotechnology today. We employ cutting-edge technology and biomedical research to resolve existing and upcoming challenges in healthcare, disease diagnosis, medication and treatment development.
Our passion is to promote the production of affordable medication and wellness products using state of the art technology, experience and know-how.
We provide research consultation and promote the training and development of tomorrow's Biomedical Research Scientists today by organising and facilitating workshops for researchers globally.
Sign up to hear from us.
An & An Global Limited is a company limited by shares registered in England & Wales No. 12774627 and VAT No. 381010539 . Registered Office: 85 Great Portland Street, London W1W 7LT
Copyright © 2022 AN & AN GLOBAL LIMITED - All Rights Reserved.